In Vivo Preclinical Studies
In Vivo Models for Drug Discovery: In vivo pharmacology is essential to evaluate the complex physiological effects of a drug in living organism. WuXi Biology provides in vivo pharmacology studies to evaluate the efficacy, safety and early toxicity of small molecules & biologics. WuXi Biology’s broad expertise and years of preclinical pharmacology experience makes us the ideal partner to conduct your in vivo experiments across all disease areas.
Disease-centric, with animal models in rodents and NHPs, expending to age-related diseases
+80 models covering:
Preclinical Integrated Services
Ex Vivo and In Vivo
In vitro biology, PK-PD and toxicology studies to provide datasets and evidence for IND-enabling
Our scientists provide drug discovery services and tailored solutions to advance your drug candidate selection in multiple disease areas. Through comprehensive discovery and technology platforms, peer-recognized scientific leadership and expertise in oncology, immunology, infectious disease, neurosciences, fibrosis, cardiovascular and metabolic disease, our teams work collaboratively to rapidly advance programs from target through to preclinical selection and beyond.
Therapeutic areas include:
Neurosciences
Autoimmune and Inflammatory diseases
Oncology & Immuno-oncology
Cardiovascular & Metabolic diseases
Liver diseases
Infectious diseases
Respiratory diseases
